Bempedoic Acid

Overview

Bempedoic acid is an ATP-citrate lyase inhibitor used as a therapeutic option for lowering low-density lipoprotein cholesterol (LDL-C) levels in adults with hypercholesterolemia. It is often used in combination with other lipid-lowering medications to achieve cholesterol targets.

API suppliers (16)

Suppliers of Bempedoic Acid evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• OPTIMUS DRUGS PRIVATE LTDIndia1 active DMF
• LEE PHARMA LTDIndia1 active DMF GMP on record
• METROCHEM API PRIVATE LTDIndia1 active DMF
• APICHEM Laboratories Private LimitedIndia1 active DMF
• Yangzhou Aurisco Pharmaceutical Co.,Ltd.China1 active DMF
• AMI LIFESCIENCES PRIVATE LTDIndia1 active DMF GMP on record
• Micro Labs Usa1 active DMF
• Everest Organics LimitedIndia1 active DMF
• Shandong New Time Pharmaceutical Co Ltd1 active DMF GMP on record
• Alkem Laboratories LimitedIndia1 active DMF GMP on record
• HONOUR LAB LTDIndia1 active DMF GMP on record
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
• SYNTHIMED LABS PRIVATE LIMITEDIndia1 active DMF GMP on record
• MOREPEN LABORATORIES LTDIndia1 active DMF GMP on record
• BIOPHORE INDIA PHARMACEUTICALS PVT LTD1 active DMF
• DR REDDYS LABORATORIES LTD1 active DMF GMP on record

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Bempedoic Acid expires 19 Jun 2040 and exclusivity 22 Mar 2027. Generic API sourcing typically opens up once these lapse.

Therapeutic areas